MDxHealth is trading at $0.65, down -7.05% in after-hours trading; the immediate trigger remains unclear despite broad market gains.
- No new company-specific announcement was identified for September 11, 2026.
- Recent searches found the latest material developments were earlier, including the Exosome Diagnostics acquisition closing and prior financial updates.
- Recheck recommended if a delayed filing or corporate release appears.